# A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

> **NCT05325853** · PHASE3 · COMPLETED · sponsor: **American Genomics, LLC** · enrollment: 61 (actual)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** AG-920
- **DRUG:** Proparacaine Ophthalmic

## Key facts

- **NCT ID:** NCT05325853
- **Lead sponsor:** American Genomics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-06
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-05-27
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05325853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05325853, "A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05325853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*